Orleans Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$418K Buy
+3,472
New +$401K 0.28% 74
2020
Q4
Sell
-3,689
Closed -$292K 79
2020
Q3
$292K Sell
3,689
-21,018
-85% -$1.65M 0.22% 65
2020
Q2
$1.82M Buy
+24,707
New +$1.86M 1.49% 28
2020
Q1
Sell
-26,179
Closed -$2.27M 65
2019
Q4
$2.27M Buy
26,179
+73
+0.3% +$6K 1.59% 27
2019
Q3
$2.1M Buy
26,106
+378
+1% +$30.3K 1.55% 26
2019
Q2
$2.06M Buy
25,728
+5,617
+28% +$430K 1.55% 30
2019
Q1
$1.6M Buy
+20,111
New +$1.5M 1.22% 38

Other funds holding MRK

Orleans Capital Management's MRK Position: Q1 2026 in Review

Orleans Capital Management opened a new position in Merck (MRK) in Q1 2026: 3,472 shares worth $418K. The stake represents 0.28% of the portfolio and ranks #74 among its holdings. This is a return to the name: Orleans Capital Management previously reported a position in MRK as recently as Q3 2020.

Orleans Capital Management first reported a position in MRK in Q1 2019 and has held it in 7 quarters since. The position peaked at $2.27M in Q4 2019. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Orleans Capital Management held 3,472 shares of Merck worth $418K as of Q1 2026.
  • Merck was a new Orleans Capital Management position in Q1 2026.
  • Merck made up 0.28% of Orleans Capital Management's portfolio in Q1 2026, its #74 holding.
  • Orleans Capital Management first reported a position in Merck in Q1 2019 and has held it in 7 quarters since.
  • Orleans Capital Management's Merck position peaked at $2.27M in Q4 2019.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Orleans Capital Management's 13F filing for Q1 2026, filed 14 May 2026.